(Q64225688)
Statements
Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen (English)
1 reference
W. A. Bleyer
P. F. Coccia
H. N. Sather
C. Level
J. Lukens
D. J. Niebrugge
S. Siegel
P. S. Littman
S. L. Leikin